Concerning the continuation of the Colorado medical board, and, in connection therewith, implementing recommendations of the department of regulatory agencies in the department's 2025 sunset report.
HB26-1307 continues the Colorado Medical Board for nine years, extending the board’s repeal date from September 1, 2026, to September 1, 2035. The bill is framed as a sunset measure and implements recommendations from the Department of Regulatory Agencies’ 2025 sunset review of the board.
In addition to the continuation, the bill makes several licensing and administrative changes. It exempts individuals facilitating natural medicine services within the scope of a natural medicine facilitator license from needing a medical license for that activity. It also changes the renewal structure for distinguished foreign teaching physician licenses so renewal is determined by the board rather than automatically annual, so long as the physician remains on a medical school’s academic staff. The bill further allows the board president to serve as a full member of licensing panel meetings and creates a new administrative license, effective January 1, 2027, for physicians whose work is limited to non-patient-facing administrative functions such as research design, analysis, quality management, patient safety protocol development, and certain teaching roles.
The administrative license is narrowly drawn: holders may not provide patient care, examine patients, order tests, prescribe, or otherwise engage in nonadministrative medical practice unless specifically authorized by rule or stipulation. The bill also exempts administrative license holders from continuing medical education requirements, while still requiring medical liability insurance and subjecting the license to renewal, reinstatement, and reactivation rules. The bill amends the state’s regulatory review statute to reflect the new 2035 repeal date for the board.
Its impact on state law is to preserve the Colorado Medical Board’s authority and operations for another nine years while refining who may practice under certain limited circumstances and how some specialized licenses are renewed. It also creates a new licensing category for physicians working in administrative or academic roles, which may affect hospitals, medical schools, research organizations, and physicians whose duties do not involve direct patient treatment. The bill was signed by the Governor, indicating final enactment.
The overall sentiment appears supportive and routine, consistent with a sunset continuation bill that largely follows agency review recommendations. No committee transcript or recorded votes were provided, so there is no evidence in the supplied materials of organized opposition or floor controversy. The main policy distinctions in the bill are technical and professional-regulatory in nature, especially around the scope of medical practice, natural medicine facilitation, and the new administrative license.
The bill amends Colorado’s medical licensing statutes to extend the Colorado Medical Board’s statutory life until September 1, 2035, and updates the state’s sunset review schedule accordingly. It also creates a new administrative physician license, modifies renewal rules for distinguished foreign teaching physician licenses, and clarifies that natural medicine facilitators acting within their licensed scope are exempt from medical licensure requirements for that activity. These changes affect the regulation of physicians, medical schools, research and quality-management roles, and the board’s licensing panel procedures.
Based on the bill text and the absence of recorded committee debate or votes in the provided materials, the bill appears to have been treated as a standard sunset continuation measure with generally favorable or noncontroversial sentiment. The inclusion of DORA sunset recommendations suggests the bill was viewed as a technical regulatory update rather than a major policy dispute. The fact that it was ultimately signed by the Governor also indicates it advanced successfully through the process.
No specific contention is documented in the supplied committee transcripts or vote history. The most likely areas for debate, based on the text, would be the scope of the new administrative license, the exemption for natural medicine facilitators, and the board’s authority to set renewal and licensure conditions by rule. Any concerns would likely come from stakeholders in medical regulation, professional licensing, natural medicine, or academic medicine, but the provided record does not show active opposition.